Physician profile
Eric Lutsky
NPI 1477530582
$26,006.67
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $257 · 2021: $25K · 2022: $45.35 · 2023: $112 · 2024: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $24,753.55 | 2021 | |
| Viiv Healthcare Company | $262.64 | 2019-2023 | Apretude |
| Lilly USA, LLC | $234.41 | 2019-2024 | Mounjaro |
| Gilead Sciences, INC. | $146.14 | 2019-2020 | |
| Novo Nordisk INC | $77.70 | 2019-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $71.43 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.84 | 2019-2020 | |
| Napo Pharmaceuticals INC | $48.60 | 2019 | |
| Abbvie INC. | $39.22 | 2021 | |
| Sandoz INC. | $38.45 | 2019-2020 | |
| Pfizer INC. | $27.93 | 2023 | |
| Hologic Sales and Service, LLC | $27.60 | 2023 | Aptima |
| Astrazeneca Pharmaceuticals Lp | $23.55 | 2019 | |
| Bioventus LLC | $21.62 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $19.21 | 2019 | |
| Genentech USA, INC. | $18.53 | 2019 | |
| Sanofi Pasteur INC. | $16.61 | 2019 | |
| Sebela Pharmaceuticals INC. | $15.71 | 2021 | |
| Integra Lifesciences Corporation | $13.26 | 2020 | |
| Allergan, INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$37,853.30 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lutsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.